IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
05 avr. 2024 09h00 HE
|
IR-Med, Inc.
Marks major milestone prior to launch in U.S. marketPressureSafe™ scanner and disposable pack both listed with FDAPressureSafe™ can support early detection of pressure injuries, potentially setting a...
IR-Med to present at National Pressure Injury Advisory Panel 2023
14 mars 2023 09h00 HE
|
IR-Med, Inc.
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...
IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY
14 févr. 2023 09h15 HE
|
IR-Med, Inc.
The study will expand to Rabin Medical Center (RMC), in parallel to Beit-Rivka, turning the study to a double center usability study. Rosh Pinna, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) --...
IRME Letter to Shareholders
11 janv. 2022 16h38 HE
|
IR-Med, Inc.
New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME). Our non-invasive monitoring technology enters the public eye – why I’m so excited for 2022. Dear new, old, and...